| FDA steps up scrutiny of stem cell therapies | | | (Reuters) - The U.S. Food and Drug Administration (FDA) is stepping up efforts to better regulate an emerging field of medicine that holds significant promise for curing some of the most troubling diseases by using the body's own cells. |
| |
| AstraZeneca taps AI for drug discovery in deal with Berg | | | LONDON (Reuters) - AstraZeneca has forged a research collaboration with Boston-based Berg, a specialist in artificial intelligence for drug hunting, in the latest sign of big pharma's interest in using supercomputers for drug discovery. |
| |
| Merck cholesterol drug cuts heart risk by 9 percent in study | | | (Reuters) - A large study of Merck & Co Inc's experimental cholesterol drug anacetrapib found that it cut the risk of heart attack and death by a modest 9 percent, which could be due to its affect on bad LDL cholesterol, researchers said on Tuesday. |
| |
| | |
